Occam Recruits Kim Blackwell to Board of NVIDIA-Backed Charm Therapeutics
In September 2025, Occam Global recruited Kim Blackwell, MD, to the Board of CHARM Therapeutics.
Kim was most recently CEO of Zentalis Pharmaceuticals, a public, clinical-stage oncology company, and previously served as Chief Medical Officer at Tempus. She joins the board as a non-executive director, bringing extensive oncology and clinical development experience, which will be crucial for the advancement of CHARM’s clinical program.
Kim earned a Bachelor's degree in Bioethics/Medical Ethics from Duke University and her MD from the Mayo Clinic Alix School of Medicine.
Occam Global is a leading executive search and advisory partner for entrepreneurs, investors, and corporations targeting exceptional goals across the life sciences, deep tech, and venture capital sectors worldwide. Since 2012, Occam has collaborated with top founders, CEOs, and investors across the tech industry to provide high-performing leaders who fuel growth. From stealth startups to public markets, we recruit senior executives, advise on organizational strategies, and invest alongside visionary teams to build innovative companies. Occam’s success is rooted in our proven ability to attract outstanding business and scientific leaders, seamless access to rare talent, and a strong commitment to results guided by high ethics and enlightened aggression. Whether you’re launching, leading, or investing, we are here to support growth through the power of talent.